Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Aug 31, 2026

Fiscal Year: 2027

View on EDGAR
Balance Sheet
38 line items · 2 periods
XBRL
ItemAug 31, 2026May 31, 2026
Assets
Current Assets:
Cash and Cash Equivalents
2,733,0001,308,000
Accounts Receivable
897,000785,000
Inventory
1,634,0001,707,000
Other Non-Operating Current Assets
145,000216,000
Total current assets
5,409,0004,016,000
Property, Plant and Equipment
68,00078,000
MEXICO
6,0008,000
Operating Lease Right-of-Use Asset
1,809,0001,873,000
Cash and Cash Equivalents
500,000500,000
Polish Distributor
165,000—
Minimum
—165,000
Maximum
—500,000
Intangible Assets
204,000209,000
Other Non-Operating Non-Current Assets
81,00083,000
Total Assets
8,071,0006,759,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
1,498,0001,171,000
Related Party
500,000500,000
Other Current Liabilities
552,000492,000
Other Current Liabilities
47,00083,000
Operating Lease Liability, Current
240,000235,000
Total current liabilities
2,837,0002,481,000
Operating Lease Liability, Non-Current
1,586,0001,648,000
Total Liabilities
4,423,0004,129,000
Shareholders’ Equity:
Total Stockholders' Equity
368,000255,000
Total Stockholders' Equity
61,567,00059,426,000
Total Stockholders' Equity
(112,000)(108,000)
Total Stockholders' Equity
(58,175,000)(56,943,000)
Total Shareholders’ Equity
3,648,0002,630,000
Common Stock
368,000255,000
Additional Paid-in Capital
61,567,00059,426,000
AOCI Attributable to Parent
(112,000)(108,000)
Retained Earnings
(58,175,000)(56,943,000)
Total Liabilities and Shareholders’ Equity
8,071,0006,759,000